The discovery of nonrandom X-inactivation of CD1a+ cells in LCH lesions in 1994 cast the first light on the perpetual malignancy versus inflammation debate on the origin of LCH, suggesting the clonality of LCH cells [12, 13]. The gene discussed is CD1A; the disease is Langerhans cell histiocytosis.